triazoles has been researched along with Communicable Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boechat, N; Castelo-Branco, FS; França, RRF; Hoelz, LVB; Menozzi, CAC | 1 |
| Buhl, C; Classen, AY; Cornely, OA; Heinz, WJ; Hoenigl, M; Karthaus, M; Khodamoradi, Y; Klein, M; Koehler, P; Koldehoff, M; Krause, R; Lass-Flörl, C; Liss, B; Maschmeyer, G; Mellinghoff, SC; Penack, O; Ruhnke, M; Schalk, E; Schmidt-Hieber, M; Sprute, R; Stemler, J; Teschner, D; Zapke, SE | 1 |
| Andes, DR; Cattaneo, D; Christian, R; Davis, MR; Johnson, MD; Lewis, RE; McCreary, EK; Narayanan, N; Watt, KM; Wiederhold, NP | 1 |
3 review(s) available for triazoles and Communicable Diseases
| Article | Year |
|---|---|
The Medicinal Chemistry of 3-nitro-1,2,4-triazoles: Focus on Infectious Diseases.
Topics: Animals; Chagas Disease; Chemistry, Pharmaceutical; Communicable Diseases; Humans; Leishmaniasis; Mycoses; Triazoles; Trypanosomiasis, African; Tuberculosis | 2021 |
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Topics: Antifungal Agents; Communicable Diseases; Cytochrome P-450 CYP3A; Hematologic Neoplasms; Hematology; Humans; Invasive Fungal Infections; Medical Oncology; Triazoles | 2023 |
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
Topics: Antifungal Agents; Communicable Diseases; Drug Monitoring; Humans; Mycoses; Pharmacists; Triazoles; Voriconazole | 2023 |